Lumos Pharma
Clinical trials sponsored by Lumos Pharma, explained in plain language.
-
Can a new pill help older adults lose weight without losing strength?
Disease control Not yet recruitingThis phase 2 trial is testing whether adding an experimental oral drug called LUM-201 to the weight-loss medication semaglutide can improve physical function in older adults with obesity. The study enrolls people aged 60 to 85 with a body mass index (BMI) between 30 and 45 who ha…
Phase 2 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a new drug combo fight childhood brain tumors that Won't stop growing?
Disease control Not yet recruitingThis early-phase trial is testing whether an experimental drug called NLG802, taken as a pill, can be safely combined with the chemotherapy drug temozolomide for children and young adults (ages 5 to 21) with progressive brain or spinal cord cancer. The study aims to find the high…
Phase 1 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Daily pill may replace growth hormone shots for children
Disease control Not yet recruitingThis study evaluates the long-term safety of an oral medication called LUM-201 for children with growth hormone deficiency (GHD). Children who completed a prior 12-month trial can receive LUM-201 daily for up to 36 additional months. The goal is to see if the pill is safe and tol…
Phase 3 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC